echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Parkinson's disease, insufficient exercise of cognitive function, or dementia

    Neurology: Parkinson's disease, insufficient exercise of cognitive function, or dementia

    • Last Update: 2022-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    People with Parkinson's disease (PD) had an almost 6-fold increased risk of developing cognitive impairment and dementia (PDD) compared to age-matched


     

    Figure 1: Cover art of the paper

    However, 24% of patients with PD-MCI returned to normal cognitive function


    To date, studies have shown that progress in IADL is associated with a deterioration in some cognitive indicators and future cognitive test performance, but the results predicting cognitive diagnosis are uncertain due to the lack of longitudinal studies


    On the cross-section, not all studies have confirmed a direct link between cognition and function in PD,10,11 which means that not all instruments are suitable for detecting cognitive-driven IADLs and may be confused



    They hypothesized that patients with both PD-MCI and cognitive IADL disorders had a higher


    First: define the baseline phenotype associated with cognitive IADL impairment, with the expectation of decreased cognitive performance, genetic risk variants associated with cognitive impairment, and high ratios of cerebrospinal fluid (CSF) biomarkers;

    Figure 2: Graph of the paper results

    Second: The study studied the progress of functions over time reflected by changes in FAQ subscores, assuming that patients with baseline classification of PD-MCI or cognitive IADL disorder had higher


    They conducted an observational longitudinal study using cognitive and clinical scores, as well as genetic and CSF biomarkers


    Of the 268 PD patients assessed at baseline, 108 (40.


    HR with baseline cognitive IADL disorder (n=37) to dementia was described as higher than PD-MCI, but highest among patients with both markers (HR=12.


    In the follow-up sample, nearly half of the patients (n=10, 47.



    Becker S, Bode M, Brockmann K, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.